banner
22UA.F image

BioNTech SE

22UA.F

XETRA

96.75

EUR
-0.65(-0.67%)

As of today

BioNTech SE fundamentals

22UA.F Cash Flow

Period EndingDec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Net Income-677,700,0001,186,100,00012,954,100,00015,046,400,000-145,802,000-179,440,000-47,662,000-85,905,000
Depreciation & Amortization311,377,142183,400,000123,300,00075,200,00038,744,00033,896,00021,984,00010,529,000
Deferred Income Tax-10,553,38600-3,794,500,00040,064,000-54,0001,044,00026,272,000
Stock-Based Compensation100,900,00051,400,000108,600,00093,900,00032,100,00030,200,0007,641,0005,909,000
Change in Working Capital1,220,600,0005,574,800,0004,518,500,000-10,730,400,000-93,097,000-83,436,000-40,961,000-7,964,000
Accounts Receivable Change387,700,0005,374,000,0004,369,900,000-11,808,100,000-247,886,0002,939,000-18,732,000-2,816,000
Inventory Change74,500,00081,900,00062,900,000-438,400,000-49,794,000-5,798,000-1,253,000-574,000
Accounts Payable Change758,400,000118,900,00085,700,0001,516,100,000204,583,000-80,577,000-20,976,000-4,574,000
Other Working Capital Change00-50,867,05800000
Other Non-Cash Items-734,100,000-1,624,300,000-4,127,100,000212,500,000114,475,000262,000-226,000-1,403,000
Net Cash Provided by Operating Activities207,700,0005,371,400,00013,577,400,000889,700,000-13,474,000-198,537,000-58,180,000-52,562,000
Investments in Property, Plant & Equipment-286,500,000-250,100,000-363,300,000-127,500,000-85,446,000-71,080,000-67,854,000-57,742,000
Net Acquisitions1,253,867-336,900,000589,193-20,800,000-60,643,000-6,056,000727,5714,877,884
Purchases of Investments-12,370,300,000-6,982,282,479-47,800,000-410,444,7050000
Sales & Maturities of Investments10,740,200,0001,191,368,354375,200,00026,500,0000000
Other Investing Activities-164,600,000-576,585,87510,807-23,100,0001,241,00021,000706,0005,193,000
Net Cash Used for Investing Activities-2,081,200,000-6,954,500,000-35,300,000-566,100,000-144,848,000-77,115,000-67,148,000-52,549,000
Debt Repayment-2,403,246-40,100,000-59,100,000-66,700,000141,700,0007,900,0003,452,000-1,643,000
Common Stock Issued00110,500,000160,900,000753,000,000375,400,000361,725,0000
Common Stock Repurchased0-738,500,000-986,400,00000000
Dividends Paid00-475,577,53900000
Other Financing Activities-43,496,75400-14,662,45325,000-10,00000
Net Cash Used/Provided by Financing Activities-45,900,000-778,600,000-1,419,300,00094,200,000894,725,000383,290,000365,177,000-1,643,000
Effect of Forex Changes on Cash14,800,000150,300,00059,600,00064,700,000-45,343,00016,000-459,000-24,820,000
Net Change in Cash-1,901,800,000-2,211,400,00012,182,400,000482,500,000691,060,000107,654,000239,389,000-131,574,000
Cash at End of Period9,761,900,00011,663,700,00013,875,100,0001,692,700,0001,210,209,000519,149,000411,495,000172,106,000
Cash at Beginning of Period11,663,700,00013,875,100,0001,692,700,0001,210,200,000519,149,000411,495,000172,106,000303,680,000
Operating Cash Flow207,700,0005,371,400,00013,577,400,000889,700,000-13,474,000-198,537,000-58,180,000-52,562,000
Capital Expenditure-452,300,000-705,500,000-363,300,000-154,000,000-85,446,000-71,080,000-67,854,000-57,742,000
Free Cash Flow-244,600,0004,665,900,00013,214,100,000735,700,000-98,920,000-269,617,000-126,034,000-110,304,000